Kerentech http://www.kerentech.com News from the Biotech and Medtech world Sun, 29 Aug 2010 09:29:50 +0000 http://backend.userland.com/rss092 en Eisai Announces Positive Results of Phase III Trial for Perampanel in Epilepsy http://www.kerentech.com/?p=5082 Body clock “drugs” could ease psychiatric disorders and jet lag http://www.kerentech.com/?p=5077 Kamada reaches rights agreement with Baxter http://www.kerentech.com/?p=5086 Roche and Aileron Alliance to Develop Stapled Peptide Drugs for Multiple Therapeutic Areas http://www.kerentech.com/?p=5068 Galapagos and University of Bristol enter drug discovery collaboration in chronic pain.Total contract value: €3.3 million http://www.kerentech.com/?p=5055 AVI BioPharma Closes New Contract With U.S. Government for Development of Therapeutic Candidates for Ebola and Marburg Hemorrhagic Fever Viruses http://www.kerentech.com/?p=5059 Watson and Itero Enter Worldwide License Agreement on Biologic Development Candidate For Female Infertility http://www.kerentech.com/?p=5053 Aricept long acting formulation benefits patients with advanced Alzheimer http://www.kerentech.com/?p=5049 Calithera Biosciences Closes $40 Million in Series A Financing for the treatment of cancer http://www.kerentech.com/?p=5044 Infinity and Intellikine sign $488M pact on Intellikine’s PI3K portfolio in cancer and inflammatory diseases http://www.kerentech.com/?p=5039